Increased NOD1, but not NOD2, activity in subcutaneous adipose tissue from patients with metabolic syndrome

Obesity

Volumn 23, Issue 7, 2015, Pages 1394-1400

  Zhou, Yi Jun ^a   Liu, Cong ^a   Li, Chun Li ^a   Song, Yu Ling ^a   Tang, Yin Si ^a   Zhou, Hui ^a   Li, Ai ^a   Li, Yan ^a   Weng, Yang ^a   Zheng, Fang Ping ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; HEMOGLOBIN A1C; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KINASE; RECEPTOR INTERACTING PROTEIN KINASE 2; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; AUTACOID; CYTOKINE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE 2; RIPK2 PROTEIN, HUMAN;

ADIPOCYTE; ADULT; ARTICLE; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INNATE IMMUNITY; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE; GENETICS; METABOLISM; OBESITY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADIPOCYTES; ADULT; CYTOKINES; FEMALE; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INFLAMMATION MEDIATORS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NOD1 SIGNALING ADAPTOR PROTEIN; NOD2 SIGNALING ADAPTOR PROTEIN; OBESITY; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASE 2; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE;

EID: 84933183345     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21113     Document Type: Article

References (27)

1. Zhou HC, Lai YX, Shan ZY, et al., Effectiveness of different waist circumference cut-off values in predicting metabolic syndrome prevalence and risk factors in adults in china. Biomed Environ Sci 2014; 27: 325-334.
2. Nishimura S, Manabe I, Nagai R., Adipose tissue inflammation in obesity and metabolic syndrome. Discov Med 2009; 8: 55-60.
3. Fuentes E, Fuentes F, Vilahur G, Badimon L, Palomo I., Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome. Mediators Inflamm 2013;2013: 136584.
4. Esser N, L'homme L, De Roover A, et al., Obesity phenotype is related to nlrp3 inflammasome activity and immunological profile of visceral adipose tissue. Diabetologia 2013; 56: 2487-2497.
5. Jialal I, Kaur H, Devaraj S., Toll-like receptor status in obesity and metabolic syndrome: a translational perspective. J Clin Endocrinol Metab 2014; 99: 39-48.
6. Bremer AA, Jialal I., Adipose tissue dysfunction in nascent metabolic syndrome. J Obes 2013;2013: 393192.
7. Watanabe Y, Nagai Y, Takatsu K., Activation and regulation of the pattern recognition receptors in obesity-induced adipose tissue inflammation and insulin resistance. Nutrients 2013; 5: 3757-3778.
8. Schertzer JD, Klip A., Give a NOD to insulin resistance. Am J Physiol Endocrinol Metab 2011; 301: E585-E856. 58
9. Correa RG, Milutinovic S, Reed JC,. Roles of NOD1 (nlrc1) and NOD2 (nlrc2) in innate immunity and inflammatory diseases. Biosci Rep 2012; 32: 597-608.
10. Moreno L, Gatheral T., Therapeutic targeting of NOD1 receptors. Br J Pharmacol 2013; 170: 475-485.
11. Zhao L, Hu P, Zhou Y, Purohit J, Hwang D., NOD1 activation induces proinflammatory gene expression and insulin resistance in 3T3-l1 adipocytes. Am J Physiol Endocrinol Metab 2011; 301: E587-E598. 5
12. Zhou YJ, Zhou H, Li Y, Song YL,. NOD1 activation induces innate immune responses and insulin resistance in human adipocytes. Diabetes Metab 2012; 38: 538-543.
13. Schertzer JD, Tamrakar AK, Magalhães JG, et al., NOD1 activators link innate immunity to insulin resistance. Diabetes 2011; 60: 2206-2215.
14. Cuda C, Badawi A, Karmali M, El-Sohemy A., Effects of polymorphisms in nucleotide-binding oligomerization domains 1 and 2 on biomarkers of the metabolic syndrome and type II diabetes. Genes Nutr 2012; 7: 427-435.
15. Bremer AA, Devaraj S, Afify A, Jialal I., Adipose tissue dysregulation in patients with metabolic syndrome. J Clin Endocrinol Metab 2011; 96: E1782 -E 1788.
16. Alberti KG, Zimmet P, Shaw J., Metabolic syndrome-a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med 2006; 23: 469-480.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC,. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
18. McTernan PG, Fisher FM, Valsamakis G, et al., Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. J Clin Endocrinol Metab 2003; 88: 6098-6106.
19. Pfaffl MW,. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.
20. Vitseva OI, Tanriverdi K, Tchkonia TT, et al., Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue. Obesity (Silver Spring) 2008; 16: 932-937.
21. Park JH, Kim YG, McDonald C, et al., RICK/rip2 mediates innate immune responses induced through NOD1 and NOD2 but not TLRs. J Immunol 2007; 178: 2380-2386.
22. Lappas M., NOD1 expression is increased in the adipose tissue of women with gestational diabetes. J Endocrinol 2014; 222: 99-112.
23. Rotter V, Nagaev I, Smith U., Interleukin-6 (IL-6) induces insulin resistance in 3T3-l1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 2003; 278: 45777-45784.
24. Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG,. Islet-associated macrophages in type 2 diabetes. Diabetologia 2009; 52: 1686-1688.
25. Shiny A, Regin B, Balachandar V, et al., Convergence of innate immunity and insulin resistance as evidenced by increased nucleotide oligomerization domain (NOD) expression and signaling in monocytes from patients with type 2 diabetes. Cytokine 2013; 64: 564-570.
26. Amar J, Chabo C, Waget A, et al., Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med 2011; 3: 559-572.
27. Zhao L, Kwon MJ, Huang S, et al., Differential modulation of NODs signaling pathways by fatty acids in human colonic epithelial hct116 cells. J Biol Chem 2007; 282: 11618-11628.